Clemens Scherzer
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
Translational Genomics of Parkinson’s Disease: Cause, Cures, DiagnosticsGoogle:
"Clemens Scherzer"Mean distance: 106866
Parents
Sign in to add mentor| David G. Standaert | research scientist | 2001-2002 | Harvard Medical School - Beth Israel Deaconess Medical Center |
Children
Sign in to add trainee| Xianjun Dong | research scientist | 2013- | Harvard Medical School - Brigham and Women's Hospital (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Simmons SK, Adiconis X, Haywood N, et al. (2024) Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data. Biorxiv : the Preprint Server For Biology |
| Hu R, Wang R, Yuan J, et al. (2024) Transcriptional pathobiology and multi-omics predictors for Parkinson's disease. Biorxiv : the Preprint Server For Biology |
| Sodders MJ, Avila-Pacheco J, Okorie EC, et al. (2024) Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's disease. Biorxiv : the Preprint Server For Biology |
| Leventhal MJ, Zanella CA, Kang B, et al. (2024) A systems-biology approach connects aging mechanisms with Alzheimer's disease pathogenesis. Biorxiv : the Preprint Server For Biology |
| Nazeen S, Wang X, Zielinski D, et al. (2024) Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies. Biorxiv : the Preprint Server For Biology |
| Romanowska J, Bjornevik K, Cortese M, et al. (2023) Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study. Neurology. 101: e2068-e2077 |
| Dong X, Bai Y, Liao Z, et al. (2023) Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease. Nature Communications. 14: 5327 |
| Giladi N, Alcalay RN, Cutter G, et al. (2023) Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. Neurology. 22: 661-671 |
| Huh YE, Usnich T, Scherzer CR, et al. (2023) Variants and Parkinson's Disease: Paving the Way for Targeted Therapy. Journal of Movement Disorders |
| Dong X, Bai Y, Liao Z, et al. (2023) Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease. Biorxiv : the Preprint Server For Biology |